We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.88%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.12B
AUM Growth
+$596M
Cap. Flow
+$91.3M
Cap. Flow %
1.28%
Top 10 Hldgs %
11.77%
Holding
645
New
72
Increased
209
Reduced
241
Closed
76

Top Sells

Rank Stock Value
1
REVG
REV Group
REVG
+$46.8M
2
UNH icon
UnitedHealth
UNH
+$43.8M
3
AZEK
The AZEK Co
AZEK
+$23.3M
4
MCK icon
McKesson
MCK
+$21.1M
5
TJX icon
TJX Companies
TJX
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 20.65%
2 Industrials 18.36%
3 Financials 15.32%
4 Healthcare 12.69%
5 Consumer Discretionary 11.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
301
Philip Morris
PM
$297B
$5.65M 0.08%
31,031
-129
-0.4% -$22.2K
TTMI icon
302
TTM Technologies
TTMI
$12B
$5.63M 0.08%
137,858
-48,117
-26% -$1.33M
LMT icon
303
Lockheed Martin
LMT
$134B
$5.57M 0.08%
12,022
IJH icon
304
iShares Core S&P Mid-Cap ETF
IJH
$122B
$5.53M 0.08%
89,090
JNJ icon
305
Johnson & Johnson
JNJ
$618B
$5.51M 0.08%
36,102
-301
-0.8% -$46.3K
SPXC icon
306
SPX Corp
SPXC
$11B
$5.51M 0.08%
32,859
+2,471
+8% +$362K
JXN icon
307
Jackson Financial
JXN
$8.53B
$5.42M 0.08%
61,017
-4,112
-6% -$333K
VWO icon
308
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$5.32M 0.07%
+107,470
New +$4.98M
HRB icon
309
H&R Block
HRB
$5.58B
$5.21M 0.07%
95,000
LAUR icon
310
Laureate Education
LAUR
$5.28B
$5.19M 0.07%
221,869
-45,606
-17% -$978K
FRPT icon
311
Freshpet
FRPT
$2.93B
$5.11M 0.07%
75,184
+12,764
+20% +$997K
CRNX icon
312
Crinetics Pharmaceuticals
CRNX
$8.84B
$5.08M 0.07%
176,517
+30,243
+21% +$934K
ADMA icon
313
ADMA Biologics
ADMA
$1.96B
$5.06M 0.07%
277,733
-18,709
-6% -$382K
PEBO icon
314
Peoples Bancorp
PEBO
$1.5B
$5.02M 0.07%
164,235
-3,883
-2% -$113K
UFPI icon
315
UFP Industries
UFPI
$4.9B
$5.02M 0.07%
50,475
-51,323
-50% -$5.18M
OUT icon
316
Outfront Media
OUT
$5.61B
$4.98M 0.07%
305,353
-83,908
-22% -$1.31M
SPT icon
317
Sprout Social
SPT
$516M
$4.96M 0.07%
237,415
+40,223
+20% +$852K
ONTO icon
318
Onto Innovation
ONTO
$12.9B
$4.85M 0.07%
48,039
+1,205
+3% +$129K
NTB icon
319
Bank of N.T. Butterfield & Son
NTB
$2.43B
$4.83M 0.07%
109,011
-7,122
-6% -$292K
YOU icon
320
Clear Secure
YOU
$5.57B
$4.73M 0.07%
170,399
+3,820
+2% +$97.3K
CALM icon
321
Cal-Maine
CALM
$4.12B
$4.72M 0.07%
47,387
-2,662
-5% -$254K
TEX icon
322
Terex
TEX
$7.18B
$4.72M 0.07%
101,116
-9,494
-9% -$397K
APEI icon
323
American Public Education
APEI
$890M
$4.72M 0.07%
154,926
-14,707
-9% -$389K
IWN icon
324
iShares Russell 2000 Value ETF
IWN
$14.3B
$4.71M 0.07%
29,867
+1,081
+4% +$161K
VPG icon
325
Vishay Precision Group
VPG
$1.22B
$4.69M 0.07%
+166,884
New +$4.11M

Similar funds

Segall Bryant & Hamill's Q2 2025 Portfolio in Review

As of Q2 2025, Segall Bryant & Hamill held 645 positions worth $7.12B, up 9.1% from $6.53B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill's Q2 2025 filing shows 72 new, 209 increased, 241 reduced and 76 closed positions. Its largest new stake was Flowserve: 345,600 shares worth $18.1M. The largest sale was REV Group, an estimated $46.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q2 2025 buy was Flowserve: 345,600 shares worth $18.1M.
  • Segall Bryant & Hamill added most to Meta Platforms (Facebook) in Q2 2025, an estimated $28.6M increase.
  • Segall Bryant & Hamill's biggest Q2 2025 reduction was REV Group, cutting an estimated $46.8M.
  • Segall Bryant & Hamill fully exited UnitedHealth in Q2 2025, selling an estimated $43.8M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.12B portfolio in Q2 2025.
  • Segall Bryant & Hamill opened 72 new positions and closed 76 in Q2 2025.
  • Segall Bryant & Hamill's portfolio value rose 9.1% quarter-over-quarter to $7.12B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2025, filed 12 Aug 2025.